Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

Completed

Conditions studied: Cervical Neoplasms, Human Papillomavirus

In brief

The purpose of the study is to assess the cumulative disease detection of greater than or equal to Cervical intraepithelial neoplasia 2 (CIN2) and greater than or equal to Cervical intraepithelial neoplasia 3 (CIN3) in the subjects over 3 years using the subject's HPV status and cytology status from the BDS-USHPV baseline results

Key facts

Study ID
NCT02267876
Run by
Becton, Dickinson and Company
People needed
6730
Starts
2014-10-01
Expected to finish
2019-05-01
Last updated by the study team
2021-02-08

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.